Dr. Sherif R. Aboseif, MD

Dr. Aboseif practices at Sherif Aboseif MD Inc in Oxnard, California.

Dr. Aboseif's NPI, 1093882995, was assigned on November 29, 2006. Dr. Aboseif holds California license A48911.

Dr. Aboseif's primary practice is Sherif Aboseif MD Inc, at 1901 Holser Walk, Oxnard, CA 93036 in Ventura County. The practice phone is (805) 976-5902.

Dr. Aboseif's primary practice is Sherif Aboseif MD Inc in Oxnard, California. Dr. Aboseif is also affiliated with Dignity Health - St. John's Regional Medical Center. The medical group on file is Unio Specialty Care, Urology, Encinitas (formerly Genesis Healthcare Partners). Dmand AI also links Dr. Aboseif to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aboseif practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Aboseif's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Aboseif is licensed in California.

CMS data shows 5,507 Medicare services from Dr. Aboseif across 27 procedure codes in 2024, for 884 Medicare patients. Medicare paid $446,445 for them.

CMS counts 884 Medicare patients who saw Dr. Aboseif in 2024. The largest group is 75 to 84, with 324 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aboseif's median patient age at 72, with 31% women.

In 2024, Dr. Aboseif wrote 2,242 Medicare Part D claims for 654 patients. 95% of them were for generic drugs. CMS names the drug for 2,116 of them, across 18 drugs with 11 or more claims each, at $107,983 in total drug cost. In 2023, CMS named 1,842 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Aboseif for performance year 2024, reported as part of a group. Dr. Aboseif accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 15 procedures of prostate resection by Dr. Aboseif, more than 72% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Aboseif in 2015. Dr. Aboseif's most frequent co-authors are Maher A. Abbas, MD, Mohammad Ali Abbass, MD and Deborah Keller, MD.

Dmand AI links Dr. Aboseif to 1 clinical trial. Conditions studied include Prostatic Neoplasms, Castration-Resistant and Prostatic Neoplasms.

CMS Open Payments shows 570 general payments to Dr. Aboseif from 54 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 53% of the total. Astellas Pharma US Inc paid the most, $5,929.